Collaborative HIV and TB activities in Myanmar under review

Image
-
0Comments

UNAIDS and the World Health Organization (WHO) recently conducted a detailed review of HIV and tuberculosis (TB) and their current statuses and collaborative activities in Myanmar.

The review was part of a collaboration with the Ministry of Health’s National Tuberculosis and AIDS Programmes. The meeting also had funding from USAID and the Global Fund against AIDS, Tuberculosis and Malaria.

The review shows that Myanmar has made notable progress against TB and HIV. The nation’s health professionals have stopped the diseases and their spread. They have used standards that were included in the 2015 Millennium Development Goals.

Unfortunately, TB and HIV continue to be two significant public health threats in Myanmar. In 2014, TB and HIV co-infections caused 4,100 deaths in the nation. There was a total of 32,000 deaths due to TB in that year alone. Myanmar is categorized as high burden for both of the diseases.

To resolve the health problem in Myanmar, UNAIDS and the WHO recommend that health professionals take strong measures to decrease the burden of the infected patients and create a better collaboration between the national TB and AIDS Programs.



Related

dummy-img

380 people die in New York state from heart disease in week ending March 12

There were 380 deaths with heart disease listed as the underlying cause reported in New York state during the week ending March 12, a 3.3 percent decrease from the previous week.

dummy-img

70 people die in New York state with COVID-19 listed as the underlying cause in week ending March 12

There were 70 deaths with COVID-19 listed as the underlying cause reported in New York state during the week ending March 12, a 20.5 percent decrease from the previous week.

dummy-img

29 people die in New York state from kidney disease in week ending March 12

There were 29 deaths with nephritis, nephrotic syndrome and nephrosis listed as the underlying cause reported in New York state during the week ending March 12, no changes from the previous week.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Vaccine News Daily.